| 2.25 0.03 (1.35%) | 11-06 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.88  |
1-year : | 4.72 |
| Resists | First : | 3.32 |
Second : | 4.04 |
| Pivot price | 2.44 |
|||
| Supports | First : | 2.15 | Second : | 1.78 |
| MAs | MA(5) : | 2.24  |
MA(20) : | 2.67 |
| MA(100) : | 4.35 |
MA(250) : | 13.08 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 8.7 |
D(3) : | 7.4 |
| RSI | RSI(14): 19 |
|||
| 52-week | High : | 32.84 | Low : | 2.15 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ZEPP ] has closed above bottom band by 29.5%. Bollinger Bands are 33.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.42 - 2.43 | 2.43 - 2.44 |
| Low: | 2.17 - 2.19 | 2.19 - 2.2 |
| Close: | 2.23 - 2.25 | 2.25 - 2.27 |
Headquartered in Hefei, China, and established in 2013, Zepp Health Corporation (known as Huami Corporation until its rebranding in February 2021) is a technology firm specializing in the creation, production, and sale of intelligent wearable devices. Operating predominantly within the People's Republic of China, the company divides its operations into two main segments: Xiaomi Wearable Products and its own-branded products and other ventures. Its diverse product range includes smart bands, watches, and scales, in addition to hearable devices, home fitness equipment like treadmills, sportswear, selected home appliances, and various smartwatch accessories. These offerings are marketed under both the Xiaomi and Amazfit brands. Zepp Health also empowers users with detailed analyses of their collected activity and biometric data, presented through intuitive charts and graphs accessible via its proprietary Zepp Life and Zepp mobile applications.
Tue, 29 Sep 2026
When Can We Expect A Profit From Zepp Health Corporation (NYSE:ZEPP)? - Simply Wall St
Wed, 02 Sep 2026
Zepp Health Corp (ZEPP) (Q2 2026) Earnings Call Highlights: Returns to Growth Amid Supply ... - Yahoo Finance
Tue, 01 Sep 2026
Zepp Health Q2 Earnings Call Highlights - Yahoo Finance
Mon, 08 Jun 2026
Zepp Health Corporation Reports First Quarter of 2026 Unaudited Financial Results - Yahoo Finance
Tue, 26 May 2026
Zepp Health Corporation to Report First Quarter 2026 Financial Results on June 8, 2026 - Yahoo Finance
Fri, 24 Apr 2026
Zepp Health Corporation Files 2025 Annual Report on Form 20-F - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Technology
|
|
|
Industry:
Consumer Electronics
|
|
| Shares Out | 8 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 22.1 (%) |
| Held by Institutions | 33.6 (%) |
| Shares Short | 350 (K) |
| Shares Short P.Month | 345 (K) |
| EPS | -6.08 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.68 |
| Profit Margin | -15.8 % |
| Operating Margin | -19.4 % |
| Return on Assets (ttm) | -4 % |
| Return on Equity (ttm) | -21.3 % |
| Qtrly Rev. Growth | 6.9 % |
| Gross Profit (p.s.) | 12.58 |
| Sales Per Share | 32.62 |
| EBITDA (p.s.) | -3.61 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -0.38 |
| PEG Ratio | 0 |
| Price to Book value | 0.19 |
| Price to Sales | 0.06 |
| Price to Cash Flow | 0 |
| Dividend | 0.4 |
| Forward Dividend | 0 |
| Dividend Yield | 17.7% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|